» Articles » PMID: 12849067

High-density Lipoprotein-associated Apolipoprotein A-I: the Missing Link Between Infection and Chronic Inflammation?

Overview
Journal Autoimmun Rev
Publisher Elsevier
Date 2003 Jul 10
PMID 12849067
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

The etiology of chronic immuno-inflammatory diseases including rheumatoid arthritis (RA), multiple sclerosis (MS), systemic lupus erythematosus (SLE), and atherosclerosis is far from being elucidated. It is generally accepted that multiple factors are involved in the development of such pathologies, including factors of genetic susceptibility that interact in complex ways with diverse environmental factors, i.e. gender, nutrition, environment, etc. Furthermore, infection has often been pinpointed as playing a causal role. However, no distinctive pattern has yet emerged from the tremendous number of compiled results that would provide a generally acceptable hypothesis of the etiology of immuno-inflammatory diseases, and the possibility of a persistent antigenic stimulus arising from an infection cannot be confirmed or refuted. At the cellular level, chronic inflammation is characterized by the infiltration of immuno-inflammatory cells into the target tissue, which mostly precedes tissue damage. At the inflammatory site, monocytes and T lymphocytes are in close proximity. We have demonstrated that contact-mediated activation of monocytes by stimulated T lymphocytes is a major stimulus triggering the production of large amounts of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) whose importance in chronic inflammation is well known. We recently established that high-density lipolipoprotein (HDL)-associated apolipoprotein (apo) A-I is a specific inhibitor of cytokine production in monocyte-macrophages upon contact with stimulated T cells. HDL-associated apo A-I is a negative acute-phase protein, i.e. a protein whose level is lowered by more than 25% during the acute phase. This review aims at highlighting the fact that HDL-associated apo A-I might play the role of a constitutive anti-inflammatory factor. The decrease of plasma levels of HDL-associated apo A-I upon acute inflammation may be a sign of the possible development of chronic inflammation, i.e. individuals presenting with risk factors might develop chronic inflammatory diseases after infection. We thus hypothesize that HDL-associated apo A-I might be the missing link between infection and chronic inflammation.

Citing Articles

Quantitative Assessment of Baseline Serum HDL-C to Predict Gout Flares During Urate-Lowering Therapy Initiation: A Prospective Cohort Study.

Jiang C, Li M, Chen Y, He Y, Li X, Cui L J Inflamm Res. 2024; 17:11235-11245.

PMID: 39717664 PMC: 11665189. DOI: 10.2147/JIR.S493376.


Identifying modifiable factors associated with neuroimaging markers of brain health.

Huang L, Fu Y, Zhang Y, Hu H, Ma L, Ge Y CNS Neurosci Ther. 2024; 30(10):e70057.

PMID: 39404063 PMC: 11474882. DOI: 10.1111/cns.70057.


Low Levels of IgM Recognizing 4-Hydroxy-2-Nonenal-Modified Apolipoprotein A-I Peptide and Its Association with the Severity of Coronary Artery Disease in Taiwanese Patients.

Lei M, Hsu P, Tsai Y, Chang C, Tsai I, Hsu H Curr Issues Mol Biol. 2024; 46(6):6267-6283.

PMID: 38921045 PMC: 11202877. DOI: 10.3390/cimb46060374.


Determinants of serum cytokines in a population sample of healthy subjects from Iran.

Mirhafez S, Zarifian A, Movahedi A, Ferns G, Sathyapalan T, Ghayour-Mobarhan M Arch Med Sci Atheroscler Dis. 2023; 8:e89-e95.

PMID: 38089159 PMC: 10711785. DOI: 10.5114/amsad/171708.


Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge.

Tamman A, Koller D, Nagamatsu S, Cabrera-Mendoza B, Abdallah C, Krystal J Neuropsychopharmacology. 2023; 49(4):699-708.

PMID: 37848731 PMC: 10876568. DOI: 10.1038/s41386-023-01747-5.